Related Experiment Video
Updated: May 12, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
Published on: September 30, 2025
High-density lipoprotein cholesterol: How High
G Rajagopal1, V Suresh, Alok Sachan
1Department of Endocrinology and Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh - 517 507, India .
Insights
High-density lipoprotein cholesterol (HDL-C), the "good cholesterol," is inversely linked to coronary heart disease (CHD) risk. Higher HDL-C levels are associated with significantly lower CHD risk, with no identified upper limit for this protective effect.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Preventive Cardiology
Background:
- High-density lipoprotein cholesterol (HDL-C) is recognized as
Purpose of the Study:
- To review the relationship between HDL-C levels and coronary heart disease (CHD) risk.
- To discuss the implications for treating low HDL-C and the role of emerging therapies.
Main Methods:
- Review of epidemiological studies correlating HDL-C levels with CHD risk.
- Analysis of the established benefits of statins.
- Overview of cholesteryl ester transfer protein (CETP) inhibitors in HDL metabolism.
Main Results:
- A clear inverse relationship exists between HDL-C levels and CHD risk.
- Higher HDL-C concentrations (above 60 mg/dL) are associated with progressively lower CHD risk.
- No upper limit for the beneficial effect of HDL-C on CHD risk has been determined.
Conclusions:
- Elevated HDL-C levels are protective against coronary heart disease.
- While statins improve CHD outcomes, the therapeutic targets for low HDL-C remain under investigation.
- Cholesteryl ester transfer protein (CETP) inhibitors are a potential therapeutic avenue, but their clinical utility requires further evaluation.
Abstract:
The high-density lipoprotein cholesterol (HDL-C) is considered anti-atherogenic good cholesterol. It is involved in reverse transport of lipids. Epidemiological studies have found inverse relationship of HDL-C and coronary heart disease (CHD) risk. When grouped according to HDL-C, subjects having HDL-C more than 60 mg/dL had lesser risk of CHD than those having HDL-C of 40-60 mg/dL, who in turn had lesser risk than those who had HDL-C less than 40 mg/dL. No upper limit for beneficial effect of HDL-C on CHD risk has been identified. The goals of treating patients with low HDL-C have not been firmly established. Though many drugs are known to improve HDL-C concentration, statins are proven to improve CHD risk and mortality. Cholesteryl ester transfer protein (CETP) is involved in metabolism of HDL-C and its inhibitors are actively being screened for clinical utility. However, final answer is still awaited on CETP-inhibitors.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis I: Introduction
